BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28099933)

  • 21. Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas.
    Margetts CD; Astuti D; Gentle DC; Cooper WN; Cascon A; Catchpoole D; Robledo M; Neumann HP; Latif F; Maher ER
    Endocr Relat Cancer; 2005 Mar; 12(1):161-72. PubMed ID: 15788647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal changes in sporadic and familial head and neck paragangliomas.
    Sevilla MA; Hermsen MA; Weiss MM; Grimbergen A; Balbín M; Llorente JL; Rodrigo JP; Suárez C
    Otolaryngol Head Neck Surg; 2009 May; 140(5):724-9. PubMed ID: 19393419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics of carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors.
    Matyakhina L; Bei TA; McWhinney SR; Pasini B; Cameron S; Gunawan B; Stergiopoulos SG; Boikos S; Muchow M; Dutra A; Pak E; Campo E; Cid MC; Gomez F; Gaillard RC; Assie G; Füzesi L; Baysal BE; Eng C; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2938-43. PubMed ID: 17535989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing for germline mutations in sporadic pheochromocytoma/paraganglioma: a systematic review.
    Brito JP; Asi N; Bancos I; Gionfriddo MR; Zeballos-Palacios CL; Leppin AL; Undavalli C; Wang Z; Domecq JP; Prustsky G; Elraiyah TA; Prokop LJ; Montori VM; Murad MH
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):338-45. PubMed ID: 24954084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.
    Gupta S; Erickson LA
    Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas.
    Schiavi F; Savvoukidis T; Trabalzini F; Grego F; Piazza M; Amistà P; Demattè S; Del Piano A; Cecchini ME; Erlic Z; De Lazzari P; Mantero F; Opocher G
    Ann N Y Acad Sci; 2006 Aug; 1073():190-7. PubMed ID: 17102086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas.
    Krawczyk A; Hasse-Lazar K; Pawlaczek A; Szpak-Ulczok S; Krajewska J; Paliczka-Cieślak E; Jurecka-Lubieniecka B; Roskosz J; Chmielik E; Ziaja J; Cierpka L; Peczkowska M; Preibisz A; Januszewicz A; Otto M; Jarzab B
    Endokrynol Pol; 2010; 61(1):43-8. PubMed ID: 20205103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary paragangliomas.
    Raygada M; Pasini B; Stratakis CA
    Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SDHA is a tumor suppressor gene causing paraganglioma.
    Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
    Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
    Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
    Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
    Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Models of parent-of-origin tumorigenesis in hereditary paraganglioma.
    Hoekstra AS; Devilee P; Bayley JP
    Semin Cell Dev Biol; 2015 Jul; 43():117-124. PubMed ID: 26067997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
    Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
    Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The
    Snezhkina A; Fedorova M; Kobelyatskaya A; Markova D; Lantsova M; Ikonnikova A; Emelyanova M; Kalinin D; Pudova E; Melnikova N; Dmitriev A; Krasnov G; Pavlov V; Kudryavtseva A
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.
    Castelblanco E; Santacana M; Valls J; de Cubas A; Cascón A; Robledo M; Matias-Guiu X
    Endocr Pathol; 2013 Dec; 24(4):199-205. PubMed ID: 24096807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.